Bazerbashi M B, Chanarin I, Denman A M
Postgrad Med J. 1980 Feb;56(652):92-101. doi: 10.1136/pgmj.56.652.92.
Observations were made on 15 patients with chronic lymphocytic leukaemia, 3 with non-Hodgkin's lymphoma, and 18 healthy controls. These include characterization of lymphocytes, assessment of humoral and cell-mediated immunity and the effect of treatment. Those responding to therapy showed a disappearance of 'null' lymphocytes from the blood with improvement in clinical and haematological parameters. Their immune capacity, however, remained unchanged or continued to deteriorate.
对15例慢性淋巴细胞白血病患者、3例非霍奇金淋巴瘤患者和18名健康对照者进行了观察。观察内容包括淋巴细胞的特征、体液免疫和细胞介导免疫的评估以及治疗效果。对治疗有反应的患者血液中“裸”淋巴细胞消失,临床和血液学参数有所改善。然而,他们的免疫能力保持不变或继续恶化。